Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System - Quiz - MDSpire

Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System

  • By

  • David P Bui

  • Denise M Hynes

  • Edwin Wong

  • Robert Vergun

  • Lei Yan

  • Yuli Li

  • Nallakkandi Rajeevan

  • Kristin Berry

  • Hung-Mo Lin

  • Yuan Huang

  • Diana J Govier

  • Mihaela Aslan

  • George Ioannou

  • Kristina L Bajema

  • September 24, 2025

  • 0 min

Share

Original Source(s)

Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System

  • by David P Bui, Denise M Hynes, Edwin Wong, Robert Vergun, Lei Yan, Yuli Li, Nallakkandi Rajeevan, Kristin Berry, Hung-Mo Lin, Yuan Huang, Diana J Govier, Mihaela Aslan, George Ioannou, Kristina L Bajema

  • September 24, 2025

Related Content

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

Effectiveness of Telemedicine vs Face-to-Face Consultation in Fighting COVID-19: Retrospective Cohort Study of Adult Patients With COVID-19 in a Primary Care Setting

SARS-CoV-2 and reproductive system: a scientometric study